Solvency ratios also known as long-term debt ratios measure a company ability to meet long-term obligations.
Paying user area
Try for free
Baxter International Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Profitability Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Debt to Equity since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
- Get full access to the entire website from $10.42/mo, or 
- get 1-month access to Baxter International Inc. for $22.49. 
This is a one-time payment. There is no automatic renewal.
We accept:
Solvency Ratios (Summary)
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).
The analysis of the financial leverage and debt-related ratios over the examined periods reveals several distinct trends and fluctuations.
- Debt to Equity Ratio
- The debt to equity ratio initially showed a gradual increase from 0.77 to 0.85 between March and December 2012. It further increased sharply to a peak of 1.78 in June 2015, indicating a higher proportion of debt relative to equity during that period. Subsequently, there was a significant decline to 0.37 by June 2016, suggesting a substantial reduction in reliance on debt financing relative to equity in the most recent periods.
- Debt to Capital Ratio
- Debt to capital ratio followed a similar trajectory, rising from 0.44 at the start of the analysis to a peak of 0.64 in June 2015. This denotes an increased share of debt in the total capital structure. In the following quarters, this ratio decreased markedly to 0.27 by June 2016, aligning with the trend observed in debt to equity ratio, reflecting deleveraging efforts or repayment of debt.
- Debt to Assets Ratio
- The debt to assets ratio demonstrated a more moderate increase from 0.28 in early 2012 to 0.47 in June 2015, indicating a growing proportion of liabilities relative to total assets. Post mid-2015, this ratio decreased to about 0.20 by the middle of 2016, showing improved asset coverage and reduced risk exposure related to the company’s liabilities.
- Financial Leverage Ratio
- The financial leverage ratio, representing the ratio of total assets to equity, also increased from 2.79 to a peak of 3.76 in June 2015, which suggests greater use of debt to finance assets during this phase. After this peak, the ratio declined to below 2, reaching 1.88 by June 2016, which corroborates the overall pattern of reduced leverage and risk mitigation through lower debt levels relative to equity following mid-2015.
Overall, the period analyzed shows a phase of increasing leverage culminating around mid-2015, followed by a notable deleveraging trend leading into 2016. This indicates a strategic shift toward lower debt dependency and possibly more conservative financial risk management in the recent periods.
Debt Ratios
Debt to Equity
| Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||||||
| Current maturities of long-term debt and lease obligations | ||||||||||||||||||||||||
| Long-term debt and lease obligations, excluding current maturities | ||||||||||||||||||||||||
| Total debt | ||||||||||||||||||||||||
| Total Baxter shareholders’ equity | ||||||||||||||||||||||||
| Solvency Ratio | ||||||||||||||||||||||||
| Debt to equity1 | ||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||
| Debt to Equity, Competitors2 | ||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||
| Medtronic PLC | ||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).
1 Q2 2016 Calculation
            Debt to equity = Total debt ÷ Total Baxter shareholders’ equity
            =  ÷  = 
2 Click competitor name to see calculations.
- Total Debt
- The total debt showed relatively stable values in the periods from early 2012 through early 2013, ranging between approximately $5.2 billion and $5.9 billion. There was a notable increase during mid-2013, peaking near $14.2 billion by mid-2015. After this peak, total debt declined sharply, dropping to around $3.2 billion by mid-2016. This pattern indicates a significant accumulation of debt in the 2013-2015 period, followed by a rapid reduction phase.
- Total Shareholders’ Equity
- Total shareholders’ equity remained fairly stable during 2012, fluctuating between approximately $6.5 billion and $7.1 billion. From mid-2013 through 2014, equity increased gradually, reaching close to $8.7 billion at the end of 2013 and maintaining a level above $8 billion through 2014. However, there was a decline in equity around the first quarter of 2015, falling to about $7.3 billion before recovering to nearly $8.8 billion by late 2015 and early 2016. By mid-2016, equity slightly decreased again to around $8.5 billion. The trend suggests moderate equity growth with some volatility during the 2015 period.
- Debt to Equity Ratio
- The debt to equity ratio remained below 1.0 for the early periods of 2012, rising gradually to 0.85 by year-end 2012. There was a sharp increase beginning in early 2013, reaching a peak ratio of approximately 1.78 by mid-2015. This indicates that debt grew faster than equity during this time. After this peak, the ratio decreased significantly, falling below 0.4 by mid-2016, signaling a strong improvement in the company’s leverage position due to debt reduction and relatively stable equity levels.
- Summary
- The data shows a period of heightened leverage from 2013 through mid-2015, characterized by a marked increase in total debt and a corresponding rise in the debt to equity ratio exceeding 1.0, indicating debt levels surpassing equity. Following this period, the company actively reduced its total debt substantially while maintaining relatively stable equity, which led to a significant decline in the debt to equity ratio below 0.4 by mid-2016. Overall, these trends demonstrate a strategic shift from increased borrowing to deleveraging and enhanced financial stability in the most recent periods observed.
Debt to Capital
| Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||||||
| Current maturities of long-term debt and lease obligations | ||||||||||||||||||||||||
| Long-term debt and lease obligations, excluding current maturities | ||||||||||||||||||||||||
| Total debt | ||||||||||||||||||||||||
| Total Baxter shareholders’ equity | ||||||||||||||||||||||||
| Total capital | ||||||||||||||||||||||||
| Solvency Ratio | ||||||||||||||||||||||||
| Debt to capital1 | ||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||
| Debt to Capital, Competitors2 | ||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||
| Medtronic PLC | ||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).
1 Q2 2016 Calculation
            Debt to capital = Total debt ÷ Total capital
            =  ÷  = 
2 Click competitor name to see calculations.
- Total Debt
- The total debt exhibited fluctuations over the observed periods. It initially increased from approximately $5.2 billion to around $9.2 billion between early 2012 and late 2014, peaking notably in the first half of 2015 at over $14.2 billion. However, from mid-2015 onward, there was a marked reduction in total debt, declining steadily to approximately $3.2 billion by mid-2016. This pattern indicates a period of increased leverage followed by a considerable deleveraging effort.
- Total Capital
- Total capital demonstrated a general upward trend from early 2012 through mid-2015, growing from roughly $11.9 billion to over $22.2 billion. After peaking in mid-2015, total capital contracted in the following periods, declining to about $11.7 billion by mid-2016. This contraction aligns with the observed reduction in total debt, suggesting an overall decrease in capital structure size.
- Debt to Capital Ratio
- The debt to capital ratio reflected changes in the balance between debt and total capital. Starting near 0.44 in early 2012, the ratio climbed gradually to a peak of 0.64 in mid-2015, indicating increased reliance on debt financing during this time. Following this peak, the ratio decreased sharply, reaching approximately 0.27 by mid-2016. This suggests a significant shift towards lower leverage and possibly stronger capitalization.
Debt to Assets
| Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||||||
| Current maturities of long-term debt and lease obligations | ||||||||||||||||||||||||
| Long-term debt and lease obligations, excluding current maturities | ||||||||||||||||||||||||
| Total debt | ||||||||||||||||||||||||
| Total assets | ||||||||||||||||||||||||
| Solvency Ratio | ||||||||||||||||||||||||
| Debt to assets1 | ||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||
| Debt to Assets, Competitors2 | ||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||
| Medtronic PLC | ||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).
1 Q2 2016 Calculation
            Debt to assets = Total debt ÷ Total assets
            =  ÷  = 
2 Click competitor name to see calculations.
The financial data reveals notable variations in the company’s debt and asset positions over the analyzed quarters. The total debt experienced fluctuations, with initial values around $5.2 billion to $5.9 billion in 2012, followed by a significant increase peaking at $14.2 billion in the second quarter of 2015, before sharply declining to approximately $3.2 billion by the second quarter of 2016.
Total assets demonstrated a generally rising trend from about $18.8 billion at the beginning of 2012 to an apex of around $30 billion in mid-2015. Subsequently, asset levels decreased markedly to below $16 billion by mid-2016, indicating a contraction in the asset base during this period.
The debt-to-assets ratio depicts important insights into leverage trends. Initially, the ratio was relatively stable at around 0.28 to 0.30 through the first year. From mid-2013, there was an upward trend reaching nearly 0.47 in mid-2015, coinciding with the peak in total debt and assets. Following this peak, the ratio decreased substantially to approximately 0.20 by the middle of 2016, reflecting both the sharp debt reduction and asset base contraction.
- Total Debt
- The data indicates periods of significant borrowing followed by aggressive debt reduction. Notably, the surge in debt in 2015 stands out, doubling approximately compared to prior levels, which may suggest strategic financing actions during this time.
- Total Assets
- Assets accumulated over the period through to mid-2015, suggesting investment or acquisition activity. The subsequent decline in assets along with debt reduction could imply divestiture or the realization of assets to deleverage the balance sheet.
- Debt to Assets Ratio
- A rising leverage ratio peaking near 0.47 indicates increased financial risk or reliance on debt financing in 2015. The sharp post-peak decline to around 0.20 suggests a shift towards a more conservative capital structure by mid-2016, potentially improving credit risk profiles.
Overall, the data portrays a phase of expansion financed by increased debt, followed by a pronounced deleveraging and asset reduction phase. This pattern suggests a tactical adjustment in the company’s capital strategy, possibly responding to market conditions or internal financial objectives aimed at reducing leverage and strengthening the balance sheet stability.
Financial Leverage
| Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||
| Total assets | ||||||||||||||||||||||||
| Total Baxter shareholders’ equity | ||||||||||||||||||||||||
| Solvency Ratio | ||||||||||||||||||||||||
| Financial leverage1 | ||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||
| Financial Leverage, Competitors2 | ||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||
| Medtronic PLC | ||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).
1 Q2 2016 Calculation
            Financial leverage = Total assets ÷ Total Baxter shareholders’ equity
            =  ÷  = 
2 Click competitor name to see calculations.
The analysis of the quarterly financial data reveals several significant trends in the company's asset base, equity position, and financial leverage over the observed periods between March 2012 and June 2016.
- Total Assets
- The company's total assets exhibited an overall upward trend from March 2012 through mid-2015, increasing from approximately $18.8 billion to a peak of around $30 billion in June 2015. This growth suggests an expansion phase or asset accumulation during this period. However, from June 2015 to June 2016, a marked decline in total assets is observed, dropping sharply to about $16 billion. This decline could indicate asset divestitures, depreciation, or other balance sheet contractions.
- Total Baxter Shareholders’ Equity
- Shareholders’ equity showed moderate growth from $6.7 billion in March 2012 to a peak near $9 billion in March 2016. The equity base generally increased in a steady manner with minor fluctuations until early 2016. Despite the volatility in total assets towards mid-2015 to mid-2016, equity remained relatively stable though with a slight decrease post-March 2016, indicating resilience in the equity structure or limited impact from the asset reductions on shareholder equity.
- Financial Leverage
- The financial leverage ratio, which measures the level of assets funded by equity, reflects notable variability. The ratio fluctuated between roughly 2.7 and 3.8 during the initial phase (2012 to mid-2015), indicating a relatively high and somewhat volatile use of debt or other liabilities to finance assets. The ratio reached its highest values in late 2014 through mid-2015, coinciding with the peak in total assets. Thereafter, a significant decline in financial leverage is observed, moving down from about 3.76 in mid-2015 to below 2.0 by June 2016. This reduction suggests a deleveraging process occurred, potentially through reducing liabilities or managing asset levels more conservatively.
In summary, the data portrays a period of expansion in asset and equity size, accompanied by increased financial leverage up to mid-2015, followed by a contraction phase with lower asset levels and a notable reduction in leverage ratios through mid-2016. These shifts may reflect strategic changes in capital structure and asset management within the company during the period examined.